跳至主要内容
临床试验/ACTRN12619000393156
ACTRN12619000393156已完成3 期

ormal saline versus heparin flushes in paediatric oncology to prevent occlusion: a pilot randomised controlled trial

Queensland Children's Hopsital0 个研究点目标入组 60 人开始时间: 2019年3月12日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
Years 至 18 Years(—)
性别
All

入选标准

  • Ages 0 – 18years
  • Have a central venous access device in situ;
  • Diagnosed with an oncological or malignant haematological condition
  • Informed consent to participate

排除标准

  • End of life pathway
  • Pre-existing coagulopathic condition not related to current diagnosis or treatment such as (but not limited to): Haemophilia A & B or other factor deficiency; Idiopathic Thrombocytopenic Purpura (ITP); Von Willibrand’s disease
  • Coagulation disorders related to current diagnosis or treatment e.g. Disseminated Intravascular Coagulopathy (DIC)
  • Current treatment with PEG-Asparaginase
  • Allergy to heparin
  • Admission to Paediatric Intensive Care Unit (PICU)
  • Admission to regional hospital or alternative healthcare facility
  • Previous study participation
  • BMT planned during study period/ or currently in progress

研究者

发起方
Queensland Children's Hopsital

相似试验